
Torrent Pharma to acquire Curatio Healthcare for ₹2,000 crore
The acquisition offers Torrent Pharma the opportunity to enhance its presence in dermatology with a differentiated portfolio.
The acquisition offers Torrent Pharma the opportunity to enhance its presence in dermatology with a differentiated portfolio.
Sun Pharma will sell Molnupiravir under the brand name Molxvir in India, Torrent Pharma will sell it as Molnutor, while Cipla will market it as Cipmolnu.